StockData
BioRestorative Therapies, Inc. logo

BioRestorative Therapies, Inc. (BRTX) stock

BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 8/30
$1.32−0.02 (-1.12%)

Close on Nov 18, 2026Market cap $33.76MP/E –Yield –

BioRestorative Therapies operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

BioRestorative Therapies's operating income for the twelve months ending Mar 31, 2026 was -$14.23M. For fiscal 2025 it was -$15.65M. The highest annual figure on record is -$2.07M in fiscal 2010.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.65M–
FY2024Dec 31, 2024-$11.56M–
FY2023Dec 31, 2023-$15.22M–
FY2022Dec 31, 2022-$18.97M–
FY2021Dec 31, 2021-$26.31M–
FY2020Dec 31, 2020-$2.75M–
FY2019Dec 31, 2019-$8.43M–
FY2018Dec 31, 2018-$7.65M–
FY2017Dec 31, 2017-$8.37M–
FY2016Dec 31, 2016-$7.79M–
FY2015Dec 31, 2015-$7.17M–
FY2014Dec 31, 2014-$4.92M–
FY2013Dec 31, 2013-$4.75M–
FY2012Dec 31, 2012-$5.57M–
FY2011Dec 31, 2011-$3.55M–
FY2010Dec 31, 2010-$2.07M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026-$3.39M–
Q4 FY2025Dec 31, 2025-$3.83M–
Q3 FY2025Sep 30, 2025-$3.71M–
Q2 FY2025Jun 30, 2025-$3.31M–
Q1 FY2025Mar 31, 2025-$4.81M–
Q4 FY2024Dec 31, 2024-$2.69M–
Q3 FY2024Sep 30, 2024-$2.29M–
Q2 FY2024Jun 30, 2024-$2.47M–
Q1 FY2024Mar 31, 2024-$4.11M–
Q4 FY2023Dec 31, 2023-$3.22M–
Q3 FY2023Sep 30, 2023-$3.10M–
Q2 FY2023Jun 30, 2023-$3.12M–
Q1 FY2023Mar 31, 2023-$5.78M–
Q4 FY2022Dec 31, 2022-$4.68M–
Q3 FY2022Sep 30, 2022-$4.61M–
Q2 FY2022Jun 30, 2022-$4.63M–
Q1 FY2022Mar 31, 2022-$5.05M–
Q4 FY2021Dec 31, 2021-$4.01M–
Q3 FY2021Sep 30, 2021-$3.69M–
Q2 FY2021Jun 30, 2021-$3.56M–
Q1 FY2021Mar 31, 2021-$15.05M–
Q4 FY2020Dec 31, 2020-$854.47K–
Q3 FY2020Sep 30, 2020-$610.27K–
Q2 FY2020Jun 30, 2020-$461.59K–
Q1 FY2020Mar 31, 2020-$818.99K–
Q4 FY2019Dec 31, 2019-$2.16M–
Q3 FY2019Sep 30, 2019-$1.82M–
Q2 FY2019Jun 30, 2019-$2.13M–
Q1 FY2019Mar 31, 2019-$2.33M–
Q4 FY2018Dec 31, 2018-$2.18M–
Q3 FY2018Sep 30, 2018-$1.19M–
Q2 FY2018Jun 30, 2018-$2.05M–
Q1 FY2018Mar 31, 2018-$2.23M–
Q4 FY2017Dec 31, 2017-$1.57M–
Q3 FY2017Sep 30, 2017-$1.74M–
Q2 FY2017Jun 30, 2017-$2.57M–
Q1 FY2017Mar 31, 2017-$2.49M–
Q4 FY2016Dec 31, 2016-$1.86M–
Q3 FY2016Sep 30, 2016-$1.72M–
Q2 FY2016Jun 30, 2016-$2.14M–

More BioRestorative Therapies figures

See a number that looks wrong?